Unknown

Dataset Information

0

Design, synthesis and biological evaluation of novel tetrahydrothieno [2,3-c]pyridine substitued benzoyl thiourea derivatives as PAK1 inhibitors in triple negative breast cancer.


ABSTRACT: The overexpression of P21-activated kinase 1 (PAK1) is associated with poor prognosis in several cancers, which has emerged as a promising drug targets. Based on high-throughput virtual screening strategy, tetrahydrothieno [2,3-c]pyridine scaffold was identified as an initial lead for targeting PAK1. Herein we reported our structure-based optimisation strategy to discover a potent PAK1 inhibitor (7j) which displayed potent PAK1 inhibition and antiproliferatory activity in MDA-MB-231 cells. 7j induced obviously G2/M cell cycle arrest via PAK1-cdc25c-cdc2 pathway, and also inhibited MAPK-ERK and MAPK-JNK cascade to induce MDA-MB-231 cell death. Together, these results provided a novel chemical scaffold as PAK1 inhibitor for breast cancer treatment.

SUBMITTER: Yao D 

PROVIDER: S-EPMC7470115 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC2606048 | biostudies-literature
| S-EPMC7181277 | biostudies-literature
| S-EPMC2915240 | biostudies-literature
| S-EPMC5438335 | biostudies-literature
| S-EPMC2961582 | biostudies-literature
| S-EPMC3213591 | biostudies-literature
| S-EPMC3200617 | biostudies-literature
| S-EPMC5237703 | biostudies-literature
| S-EPMC6964266 | biostudies-literature
| S-EPMC4011289 | biostudies-literature